GlassScriptPhysician profile
Amy S Ross
NPI 1659564193
$1,898.50
in general payments reported to CMS, 2019-2025
14 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.41 · 2020: $582 · 2021: $595 · 2022: $35.13 · 2023: $74.26 · 2024: $50.18 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $588.73 | 2019-2020 | |
| Merz North America, INC. | $378.77 | 2021 | |
| Incyte Corporation | $345.34 | 2021-2025 | Opzelura |
| Abbvie INC. | $145.38 | 2022-2025 | Skyrizi |
| Revance Therapeutics, INC. | $141.96 | 2025 | Daxi |
| Galderma Laboratories, L.P. | $62.84 | 2020-2024 | |
| Kerecis Limited | $59.27 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Novartis Pharmaceuticals Corporation | $44.04 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $28.11 | 2025 | Dupixent |
| Allergan, INC. | $22.29 | 2020 | |
| Biofrontera INC. | $22.00 | 2025 | Ameluz |
| Almirall LLC | $20.44 | 2025 | Klisyri |
| Organon LLC | $20.17 | 2025 | Vtama |
| Janssen Biotech, INC. | $19.16 | 2023 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.